Your browser doesn't support javascript.
loading
Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial.
Takeda, Masayuki; Yamanaka, Takeharu; Seto, Takashi; Hayashi, Hidetoshi; Azuma, Koichi; Okada, Morihito; Sugawara, Shunichi; Daga, Haruko; Hirashima, Tomonori; Yonesaka, Kimio; Urata, Yoshiko; Murakami, Haruyasu; Saito, Haruhiro; Kubo, Akihito; Sawa, Toshiyuki; Miyahara, Eiji; Nogami, Naoyuki; Nakagawa, Kazuhiko; Nakanishi, Yoichi; Okamoto, Isamu.
Afiliación
  • Takeda M; Department of Medical Oncology, Faculty of Medicine, Kinki University, Osaka, Japan.
  • Yamanaka T; Department of Biostatistics, Yokohama City University, Yokohama, Japan.
  • Seto T; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Hayashi H; Department of Medical Oncology, Kishiwada City Hospital, Osaka, Japan.
  • Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Okada M; Department of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
  • Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Daga H; Department of Clinical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Hirashima T; Department of Thoracic Malignancy, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka, Japan.
  • Yonesaka K; Department of Medical Oncology, Izumi Municipal Hospital, Izumi, Japan.
  • Urata Y; Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Murakami H; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Saito H; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Kubo A; Division of Respiratory Medicine and Allergology, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Sawa T; Division of Respiratory Medicine, Gifu Municipal Hospital, Gifu, Japan.
  • Miyahara E; Department of Surgery, Saiseikai Hiroshima Hospital, Hiroshima, Japan.
  • Nogami N; Department of Thoracic Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.
  • Nakagawa K; Department of Medical Oncology, Faculty of Medicine, Kinki University, Osaka, Japan.
  • Nakanishi Y; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Cancer ; 122(7): 1050-9, 2016 Apr 01.
Article en En | MEDLINE | ID: mdl-26828788
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Bevacizumab / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Bevacizumab / Neoplasias Pulmonares / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Año: 2016 Tipo del documento: Article País de afiliación: Japón